BRAF and non-small cell lung carcinoma: The treatment of advanced NSCLC is based on the detection of different AGAs, such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), c-ros oncogene 1 (ROS1), rearranged during transfection (RET), Kirsten rat sarcoma virus (KRAS), B-Raf proto-oncogene (BRAF), and mesenchymal–epithelial transition factor receptor (MET) genes [72].